Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP). oleh Xiao-Long Qian, Jun Zhang, Pei-Ze Li, Rong-Gang Lang, Wei-Dong Li, Hui Sun, Fang-Fang Liu, Xiao-Jing Guo, Feng Gu, Li Fu